September 14, 2020

Global markets

World stock markets are up this morning, driven by resumption of AstraZeneca vaccine testing and news of major acquisitions.

In Asia, exchanges closed higher. Japan's Nikkei 225 index rose 0.65%, while South Korea's Kospi index advanced 1.30%.

In China, Shanghai SE rose 0.57%. Hong Kong's Hang Seng index rose 0.56%.Japanese technology conglomerate SoftBank Group has announced the sale of the chip company Arm Holdings in the United Kingdom to US company Nvidia for $ 40 billion.

Another operation that helps to animate the markets is the purchase of Immunomedics by the American Gilead Sciences, for US $ 21 billion.

New York stock market futures indices rose sharply after accumulating a drop in the first two weeks of the month. Technology stocks are leading the way, reacting to the news that Oracle has surpassed Microsoft and is expected to take TikTok operations in the United States.

International WTI oil futures (NYMEX: CL \ V20) are trading at $ 37.21, down -0.3%. Brent (NYMEX: BZ \ V20) also operates down -0.3%, trading at $ 39.72.

Bitcoin (COIN: BTCUSD) trades at $ 10,427. Gold (COMEX: GC \ U20) is traded at $ 1,943 per troy ounce.

⇒ The conditions that make gold an attractive investment 

Iron ore futures contracts traded on the Dalian exchange closed up 2.41%, quoted at 848,500 yuan, equivalent today to $ 124.36.

Coronavirus

AstraZeneca resumes testing of the vaccine against Covid-19 on Monday (14).Tests of the Covid-19 vaccine developed by laboratory researchers in the United States and Germany from Pfizer and BioNTech, which are in the final testing phase, can be extended to more people.

The companies have requested the Food and Drugs Administration (FDA), an agency that acts like Anvisa in the United States, the authorization to apply the doses to over 14 thousand people.

The world records 29,026,240 cases of coronavirus and 924,643 deaths, confirmed today by Johns Hopkins University.

Brazil has totaled 4,330,455 cases since the beginning of the pandemic and 131,625 deaths.